Search Results

Healthy Minds Brings Together Researchers and Data to Solve Mysteries of the Brain, Commits Key Research Programs to Public Sector, and Addresses Stigma

Innovative Medicine

November 7, 2011

New Sirukumab (CNTO 136) Phase 2 Data Show Efficacy of Interleukin-6 Inhibitor across Multiple Dose Regimens in Treatment of Rheumatoid Arthritis

Subcutaneously Administered Monoclonal Antibody Improved Signs and Symptoms and Reduced Inflammation in Patients with Active Rheumatoid Arthritis

Innovative Medicine

November 6, 2011

INCIVO® (telaprevir) Demonstrates Efficacy and Increased Cure Rates among Cirrhotic Patients with Genotype-1 Chronic HCV Compared to Standard of Care

Data presented at AASLD 2011 highlights efficacy in typically hard to treat patients

Innovative Medicine

November 5, 2011

Tibotec To Present Final Safety And Efficacy Results From Phase 2b PILLAR Study Of Once-Daily TMC435 In Late-Breaker At AASLD

Data Show High Rates Of Virologic Response And Shortened Treatment Duration; Safety And Tolerability Comparable To Placebo

Innovative Medicine

November 4, 2011

FDA Approves XARELTO® (Rivaroxaban) To Reduce The Risk Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation

XARELTO® Combines Proven Effectiveness And Demonstrated Safety Profile With Convenient, Once-Daily Dosing

Search Results

No Results

Search Results

You are now leaving jnj.com/innovativemedicine